Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Deregulation of Hippo kinase signalling in Human hepatic malignancies

Open access
Li, Hua, Wolfe, Andy, Septer, Seth, Edwards, Genea, Zhong, Xiaobo, Bashar Abdulkarim, Ahmad, Ranganathan, Sarangarajan, Apte, Udayan·2012·Liver International

Abstract

Background/Aims: Hepatocellular carcinoma (HCC), cholangiocarcinoma (CC) and hepatoblastoma (HB) are the main hepatic malignancies with limited treatment options and high mortality. Recent studies have implicated H ippo kinase pathway in cancer development, but detailed analysis of H ippo kinase signalling in human hepatic malignancies, especially CC and HB, is lacking. Methods: We investigated H ippo kinase signalling in HCC, CC and HB using cells and patient samples. Results: Increased expression of yes‐associated protein (Y ap), the downstream effector of the H ippo kinase pathway, was observed in HCC cells, and si RNA‐mediated knockdown of Y ap resulted in decreased survival of HCC cells. The density‐dependent activation of Hippo kinase pathway characteristic of normal cells was not observed in HCC cells and CCLP cells, a cholangiocarcinoma cell line. Immunohistochemistry of Y ap in HCC, CC and HB tissues indicated extensive nuclear localization of Y ap in majority of tissues. Western blot analysis performed using total cell extracts from patient samples and normal livers showed extensive activation of Y ap. Marked induction of G lypican‐3, CTGF and S urvivin, the three Y ap target genes was observed in the tumour samples. Further analysis revealed significant decrease in expression and activity of Lats kinase, the main upstream regulator of Y ap. However, no change in activation of Mst‐2 kinase, the upstream regulator of Lats kinase was observed. Conclusions: These data show that Y ap induction mediated by inactivation of L ats is observed in hepatic malignancies. These studies highlight H ippo kinase pathway as a novel therapeutic target for hepatic malignancies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1478-3231.2011.02646.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 168

Metadata

Authors
Li, H., Wolfe, A., Septer, S., Edwards, G., Zhong, X., Bashar Abdulkarim, A., Ranganathan, S., & Apte, U.
Venue
Liver International
Publisher
Wiley
Published
2011-10-20
Volume
32
Issue
1
Pages
38-47
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2170664715
Cited by
168
References
2
FWCI
3.13
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deregulation of Hippo kinase signalling in Human hepatic malignancies. https://app.cochat.ai/papers/10.1111/j.1478-3231.2011.02646.x
The paper
Li, H., Wolfe, A., Septer, S., Edwards, G., Zhong, X., Bashar Abdulkarim, A., Ranganathan, S., & Apte, U. (2012). Deregulation of Hippo kinase signalling in Human hepatic malignancies. Liver International. https://doi.org/10.1111/j.1478-3231.2011.02646.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.